Home > PE Ratio > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
PE (Price/Earnings) Ratio

The Current P/E Ratio of ONESOURCE SPECIALTY PHARMA is 839.28.

Share Price ₹1,600.8May 08,2025
Market Cap ₹18,313.2 Cr
Earnings-TTM₹21.8 CrTTM-Standalone Results
Price/Earnings839.28xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of ONESOURCE SPECIALTY PHARMA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of ONESOURCE SPECIALTY PHARMA is calculated as :

Current Market Cap [ ₹18,313.2 Cr] as on May 08,2025

(/) Earnings [ ₹21.8 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 839.28x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay 839.28 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ONESOURCE SPECIALTY PHARMA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.

Historical PE (Price/Earnings) ratio chart of ONESOURCE SPECIALTY PHARMA


PE Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA

- ONESOURCE SPECIALTY PHARMA 's latest p/e ratio is 839.28x.

- ONESOURCE SPECIALTY PHARMA 's p/e ratio for fiscal years ending to May 08,2025 averaged nanx.

- ONESOURCE SPECIALTY PHARMA 's operated at median p/e ratio of x from fiscal years ending March 2018 to 2022.

- Looking back at the last 0 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/e ratio peaked in at x.

- ONESOURCE SPECIALTY PHARMA 's p/e ratio hit its five-year low in of x.


How does ONESOURCE SPECIALTY PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
ONESOURCE SPECIALTY PHARMA 21.82839.2818,313.2
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0036.89423,771.0
DIVIS LABORATORIES LTD2,067.0076.52158,175.0
CIPLA LTD5,000.4324.01120,076.0
TORRENT PHARMACEUTICALS LTD1,862.0057.86107,727.0
DR REDDYS LABORATORIES LTD5,428.6017.6695,853.9
MANKIND PHARMA LTD2,050.7348.97100,426.0
ZYDUS LIFESCIENCES LTD4,591.8019.1187,728.5
LUPIN LTD2,892.1031.7991,953.4
AUROBINDO PHARMA LTD3,500.2519.2267,274.2
ABBOTT INDIA LTD1,334.4647.8163,795.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ONESOURCE SPECIALTY PHARMA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 17.66x
Max industry PE 839.28x
Median industry PE 36.89x
Average industry PE 110.83x



You may also like the below Video Courses